Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04832152 · ClinicalTrials.gov registry record · NA

Telehealth Intervention for Autism Spectrum Disorder

A NA study of Autism Spectrum Disorder, sponsored by Thomas Jefferson University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04832152 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 10 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04832152, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by Thomas Jefferson University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Autism Spectrum Disorder (ASD) is one of the most frequently occurring childhood-onset neurodevelopmental disorders affecting 1 in every 54 children. Most children with ASD experience challenges participating in daily activities (e.g.: eating, sleeping, bathing, grooming, playing, etc.) and receive occupational therapy intervention to address these. The COVID-19 pandemic has restricted in-person therapy for many of these children and there is an urgent need for evidence-based, validated telehealth intervention. This project will adapt an evidence-based occupational therapy intervention, termed OT4ASD to a telehealth delivery model. The aims of the project are to: 1) adapt the existing intervention protocol to a telehealth delivery model, 2) train therapists and evaluate the therapist's ability to conduct OT4ASD, 3) determine if OT4ASD delivered via the telehealth is acceptable and feasible to parents and interventionists; and 4) whether children improve in the daily living skills. OT4ASD follows a systematic protocol and uses active, individually-tailored sensory motor activities that are specifically designed to address the child's needs. The investigators believe this will be the first telehealth manualized protocol to address the sensory motor symptoms of ASD and measure outcomes at the daily life activity and participation levels.

Conditions Studied

Interventions

  • OTHER OT4ASD

Study Locations (1)

New York

  • Rose R. Kennedy Children's Evaluation and Rehabilitation Center (CERC) at Montefiore - The Bronx

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-03-01
Est. Completion 2024-06-30
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT04832152

The ClinicalTrials.gov registry entry for NCT04832152 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (93% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which OT4ASD is the first listed.

NCT04832152 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04832152 about?

NCT04832152 is a clinical study titled "Telehealth Intervention for Autism Spectrum Disorder". Autism Spectrum Disorder (ASD) is one of the most frequently occurring childhood-onset neurodevelopmental disorders affecting 1 in every 54 children. Most children with ASD experience challenges participating in daily activities (e.g.: eating, sleeping, bathing, grooming, playing, etc.) and receive ...

What is the current status of trial NCT04832152?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-03-01. Estimated completion is 2024-06-30.

What conditions does trial NCT04832152 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT04832152?

The interventions under investigation include: OT4ASD (OTHER).

Who is sponsoring clinical trial NCT04832152?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04832152 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.